Objectives: The goal of this study was to investigate the epidemiological characteristics and the surrounding genetic structure of bla NDM-1 in non-baumannii Acinetobacter spp. in China.
Introduction
The clinical infections caused by the genus Acinetobacter have long been recognized as a serious problem in many countries, especially for patients in intensive care units (ICUs). 1 -3 Routine phenotypic tools have not been able to distinguish Acinetobacter spp., especially the four interspecies of the Acinetobacter calcoaceticusAcinetobacter baumannii complex (ABC), because they are closely related. 4 Due to the development of accurate molecular methodologies, reports of infections caused by non-baumannii Acinetobacter spp. have increased in the last decade. 5 -7 In general, non-baumannii Acinetobacter isolates are susceptible to ciprofloxacin, ampicillin/ sulbactam, gentamicin and tigecycline. 8 The occasional institutional outbreaks and sporadic reports of carbapenem-resistant nonbaumannii Acinetobacter spp. are important warnings and reminders of their potential threat to public health. 9 -12 Recently, the carbapenem resistance mediated by serine b-lactamases and metallo-b-lactamases (MBLs), such as KPC b-lactamase in Klebsiella pneumoniae, OXA enzymes in A. baumannii and NDM-1 carbapenemase in Enterobacteriaceae, has become a global concern. 2, 13, 14 The bla NDM-1 gene encodes an MBL carbapenemase that has a high hydrolytic activity for carbapenem antibiotics, and NDM-1-producing strains are most frequently found in Escherichia coli and K. pneumoniae. 15 -20 Previous reports on bla NDM-1 focused on its epidemiological dissemination in different countries, the antibiotic phenotypes of different species or the complete sequences of specific plasmids. 16, 21 Recent surveys have further demonstrated the high similarity of the genomic region surrounding the bla NDM-1 gene among members of Enterobacteriacae, 22 prompting experts to investigate the genetic background and evolutionary origin of the gene. Moreover, bla NDM-1 -positive plasmids revealed by complete genome sequencing in E. coli indicated a broad host range and multiple mobile genetic elements, and highlighted the potential for the extensive spread of this determinant of resistance. 16 There have been several studies of bla NDM-1 in China; however, none was based on large samples. 16, 23, 24 To evaluate the potential threat of bla NDM-1 to public health in China, we investigated the prevalence of the bla NDM-1 gene in clinical isolates of Gramnegative bacilli. Our previous study demonstrated that, from a total of 11298 isolates, including A. baumannii, Pseudomonas aeruginosa, E. coli and K. pneumoniae, only four A. baumannii isolates carried the bla NDM-1 gene and it was harboured on different plasmids. 25 Here, we further elucidate the clinical characteristics of bla NDM-1 -positive non-baumannii Acinetobacter spp. and investigate the genomic structure of the bla NDM-1 gene.
Materials and methods

Bacterial strains
A national survey of multidrug-resistant Acinetobacter spp. was conducted in China from January 2009 to September 2010. A total of 726 isolates negative for the bla OXA-51 -like gene by PCR amplification were identified as non-baumannii Acinetobacter spp. 26 These isolates, which were collected from 28 provinces, were further assayed for antimicrobial susceptibility using the Kirby-Bauer diffusion test and were screened for the presence of a bla NDM-1 gene fragment as previously described. 25 Species identification and antimicrobial susceptibility bla NDM-1 -positive isolates were first tested using the Vitek 2 system (bioMérieux, France) to distinguish the ABC. Further differentiations within the ABC were performed using the 16S-23S rRNA gene intergenic spacer (ITS) sequence, whereas other polymorphisms were investigated by amplified rDNA restriction analysis (ARDRA), as previously described. 27 -29 Lastly, partial RNA polymerase b-subunit (rpoB) sequencing was performed to differentiate the remaining unidentified strains. 29 The MICs of 15 antibiotics, together with the MBL phenotype test, were determined using the Etest (AB bioMérieux, Sweden). The susceptibility results were interpreted according to the CLSI guidelines. 30 The MIC breakpoint of cefoperazone for Enterobacteriaceae was used for cefoperazone/sulbactam. Due to the absence of CLSI criteria, the BSAC breakpoint and the FDA breakpoint for Enterobacteriaceae were applied for aztreonam and tigecycline, respectively. 31, 32 Quality controls were included using standard strains (E. coli ATCC 25922, E. coli ATCC 35218 and P. aeruginosa ATCC 27853).
Plasmid analysis and Southern hybridization
Total bacterial DNA prepared in agarose plugs was digested with S1 nuclease and separated using a CHEF-Mapper XA PFGE system (Bio-Rad, USA) to distinguish the plasmids as previously reported. 25 The PFGE conditions were 16 h at 6 V/cm and 148C, with a pulse angle of 1208 and initial and final pulses conducted for 2.16 and 63.8 s, respectively. 33 The gel was stained with GelRed (Biotium, USA) according to the manufacturer's instructions and visualized using a 254 nm UV light.
The separated DNA fragments were transferred to nylon membranes (Millipore, USA), hybridized with digoxigenin-labelled bla NDM-1 -specific probes and detected using an NBT/BCIP colour detection kit (Roche Applied Sciences, Germany). The bla NDM-1 -positive A. baumannii ABCA207 strain was included as a quality control. 25 Conjugation and electrotransformation E. coli J53 (azide resistant) was utilized as a recipient, and filter mating was performed with the bla NDM-1 -positive isolates on a filter membrane resting on MH agar without antibiotics. After 18 h of incubation, the mixed cultures were plated onto MH agar containing ampicillin (50 mg/L) and azide (200 mg/L). Transconjugants were picked after 48 h of incubation and were tested for the presence of the bla NDM-1 gene by PCR. Conventional biochemical methods and antimicrobial susceptibility testing using Etest strips were performed on the bla NDM-1 -positive transconjugants.
The plasmid DNA of the bla NDM-1 -positive isolates was extracted using a QIAGEN Plasmid DNA Midi Kit (QIAGEN, Germany) and then electrotransformed into Acinetobacter baylyi ADP1. The transformants were selected on MH agar plates containing 1 mg/L meropenem, and the presence of the bla NDM-1 gene was identified using PCR. The species identification and antimicrobial susceptibility of the bla NDM-1 -positive transformants were determined using the partial rpoB gene sequence analysis described above and Etest, respectively. 29 
DNA cloning and primer walking
The cloning experiments on the bla NDM-1 -positive strain ABC7926 were performed using pET28a as the cloning vector. The total DNA of ABC7926 was extracted using a QIAamp DNA Mini Kit (QIAGEN, Germany). Both the vector and the total DNA were digested with restriction endonuclease HindIII (Takara Inc., China), and the ligation products were transformed into chemically competent E. coli DH5a. The transformants were selected on MH agar plates containing ampicillin (50 mg/L) and then tested for the presence of the bla NDM-1 gene by PCR. Both strands of the cloned inserts containing bla NDM-1 were sequenced completely.
To explore the bla NDM-1 genomic structure, the walking primers obtained from strain ABC7926 were used to amplify the sequences of the remaining strains, and the PCR amplicons were sequenced.
Nucleotide sequence accession numbers
The nucleotide sequence data reported here have been submitted to the GenBank database with the assigned accession numbers JQ080305 (strain ABC7926), JQ739157 (strain ABCA95) and JQ739158 (strain ABZ78).
Results
Epidemiological and clinical features of the bla NDM-1 -positive isolates
From a total of 726 clinical non-baumannii Acinetobacter isolates, nine were found to be positive for the bla NDM-1 gene. According to the epidemiological data for the nine corresponding patients, six were ≥65 years old, one was 7 years old, and the other two were 28 and 45. The samples obtained for culture included sputum (n ¼5), blood (n¼ 2), urine (n ¼1) and undefined secretion (n¼ 1). These nine isolates were distributed in seven wards and scattered among six different provinces in China ( Table 1 ). The patient histories were confirmed as lacking any foreign travel. With the exception of one patient who died of cancer, all of the patients fully recovered. Most of the patients received empirical antibiotic treatment, including ceftriaxone, meropenem, imipenem, piperacillin/tazobactam, ampicillin/sulbactam, amikacin, levofloxacin or trimethoprim/sulfamethoxazole, during their hospitalization.
bla NDM-1 in non-baumannii Acinetobacter 
Species identification and antimicrobial susceptibility testing
By combining the data obtained from four methods of species determination, we precisely classified the NDM-1-producing strains to seven different Acinetobacter spp., including Acinetobacter pittii (n¼ 3), Acinetobacter lwoffii (n¼ 1), Acinetobacter johnsonii (n¼ 1), Acinetobacter genospecies 10 (n¼ 1), Acinetobacter haemolyticus (n ¼1), Acinetobacter junii (n¼ 1) and Acinetobacter genospecies 15TU (n¼ 1) ( Table 1) . Nine of the isolates were positive for the MBL phenotype and highly resistant to both carbapenems and broad-spectrum cephalosporins, but showed variable susceptibilities to fluoroquinolones and aminoglycosides. More significantly, there were two strains (ABC7980 and ABCA242) that demonstrated tigecycline resistance, with MICs ≥8 mg/L.
Plasmid analysis, conjugation and electrotransformation
According to PFGE and the corresponding Southern blot hybridizations, all strains contained more than one plasmid, and bla NDM-1 was exclusively located on diverse plasmids, with sizes ranging from 30 to 55 kb (Figure 1) .
The plasmids harbouring the bla NDM-1 gene were transferable to E. coli J53 and A. baylyi ADP1. The transconjugants were resistant to all cephalosporins and b-lactam/b-lactamase inhibitor combinations but sensitive to aztreonam, fluoroquinolones, aminoglycosides and carbapenems, and negative for the MBL phenotype, a finding that might be related to the differences between the Acinetobacter donor and the Enterobacteriaceae recipient. A. baylyi ADP1 transformants exhibited relatively high resistance to carbapenems and cephalosporins (Table 2) , showing an MBL-positive phenotype.
Analysis of the bla NDM-1 gene environment An 11.7 kb fragment from total DNA of strain ABC7926 was obtained. The fragment was entirely sequenced by primer walking, revealing 99% identity to the sequence reported for A. baumannii 161/07 (accession number HQ857107). 34 The bla NDM-1 gene was flanked by two copies of ISAba125, with a downstream trpF gene, followed by groS, groL and a truncated insE gene (Figure 2b) . The average G +C content (%) of the region between these two copies of ISAba125 was 63%, which was markedly higher than the surrounding sequences (24%-33%) (Figure 2a) . Further sequence analysis revealed that the region flanking the two copies of ISAba125 was similar to that described for element Tn5393d (accession number AJ627643.4), containing an aphA6 gene and a truncated ISAba14 gene. A 3 bp (GTT) target site duplication was found at both extremities of the two copies of ISAba125 (Figure 2b) .
The other NDM-producing strains showed similar genetic structures surrounding the bla NDM-1 gene, with the exception of ABCA95 and ABZ78, for which only 4458 and 4497 bp fragments were obtained.
Discussion
The global distribution of the bla NDM-1 gene has been extensively described. 21 However, the potential presence of this gene in nonbaumannii Acinetobacter spp. does not receive sufficient attention, and only one NDM-1-positive A. pittii has been reported. 35 In this study, we retrospectively investigated the prevalence of bla NDM-1 in non-baumannii Acinetobacter spp. in China and discovered several epidemiological features.
Based on the detailed clinical information, patients aged ≥65 years may be more susceptible, and sputum was the main sample source. Other clinical characteristics, e.g. diagnosis, ward, origin and genomic species, were not unique (Table 1) . bla NDM-1 in non-baumannii Acinetobacter None of the nine isolates was associated with a high risk of patient death or an epidemiological link to a transfer between countries. These data, together with our previous research, 25 suggest that the alarming potential of NDM-1-producing bacteria has yet to be realized in China.
In addition, we found that the NDM-1 strains were highly resistant to all antibiotics except tigecycline and colistin (Table 2) . Indeed, the therapeutic agents prescribed to the patients were followed by empirical antibiotic treatment paradigms rather than the results of antimicrobial susceptibility. Thus, the antibiotics used could not have been effective for the control of infections produced by NDM-1 strains. This intriguing finding further convinced us that the NDM-1 isolates were very likely not directly infectious to the patients but appeared to be colonizers. Unfortunately, we were unable to obtain further information and culture data for each patient, which would be helpful in revealing the clinical significance of these isolates.
The genus Acinetobacter currently comprises up to 34 species, as revealed by DNA-DNA hybridization. 36 We used the bla OXA-51 -like gene to exclude A. baumannii from other Acinetobacter isolates. Despite several reports of its existence in non-baumannii Acinetobacter isolates, 12 the bla OXA-51 -like gene is intrinsic to A. baumannii and has been used for A. baumannii identification. 26 To clarify the species reliably, four methods were utilized in this study for the NDM-1 strains. The phenotypic test using the Vitek 2 system is only a presumptive method and is far from being suitable for the exact identification of Acinetobacter spp. 4 Therefore, the 16S-23S rRNA ITS sequence and ARDRA were also used in this study for further identification. It has been reported that ITS sequence-based identification is a reliable tool to differentiate among the species in the ABC, A. calcoaceticus, A. baumannii, A. pittii and Acinetobacter genospecies 13TU. 27 Following this method, three strains were identified as A. pittii. Regarding species for which ITS sequences are unavailable, the ARDRA identified four different species: A. lwoffii, Acinetobacter genospecies 10, A. haemolyticus and A. junii. However, two additional strains could not be detected by the above methods. According to Nemec et al., 28 partial rpoB sequencing can be employed for species identification in the genus Acinetobacter; the two remaining strains, ABC4918B and ABC996, showed a close identity with A. johnsonii and Acinetobacter genospecies 15TU, respectively (Table 1) . Species determination in the genus Acinetobacter, especially non-baumannii Acinetobacter spp., is a very complicated and difficult process. Therefore, with the isolates carrying the bla NDM-1 gene reported here, the development of a novel and more accurate typing methodology would be helpful in exploring the clinical significance of non-baumannii Acinetobacter spp.
Our analysis of the genetic environment of bla NDM-1 revealed a common transposon structure composed of two copies of ISAba125; this region was very similar to that described for A. baumannii 161/07, in which bla NDM-1 was located on the bacterial chromosome. 34 In contrast, the 3 bp target site duplication indicated that an insertion occurred in the non-coding region downstream of the aphA6 gene in ABC7926, whereas the transposon was inserted into the gene encoding MFS in A. baumannii 161/07 (Figure 2b ). The upstream and downstream sequences of the transposon could be aligned with Tn5393d in Alcaligenes faecalis with 95% and 97% identity, respectively (Figure 2a) . Because fragments corresponding to the extremities of ISAba125 were identified in the sequences upstream of bla NDM-1 in E. coli DVR22 (accession number JF922606.1), pNDM-HK (accession number HQ451074), pKpANDM-1 (accession number FN396877) and p271A (accession number JF785549), we concluded that the ISAba125 insertion sequence played an important role in the mobilization of bla NDM-1 from a progenitor to Acinetobacter spp. and that further transfer events mediated by other insertion elements, such as ISEc33, ISSen4 and IS26 (accession number JF785549), ensued between Acinetobacter spp. and Enterobacteriaceae. Our characterization of the genomic environment of bla NDM-1 was limited by the restriction endonuclease cloning method employed. To complete the genetic characterization of this new carbapenemase gene, further sequencing of the plasmid carrying bla NDM-1 should be performed using high-throughput sequencing, especially for isolates ABCA95 and ABZ78. Given the presence of these determinants of resistance within mobile elements and the genetic potential of Acinetobacter spp. for acquiring foreign DNA from the environment, 37 our results indicate the potential for spread of bla NDM-1 via mobile elements from the genus Acinetobacter to Enterobacteriaceae on the Chinese mainland, although to date this gene has only been reported in Acinetobacter spp. There are increasing reports suggesting that antibiotic resistance genes in human pathogens have environmental origins. 38, 39 Zheng et al. 40 presented an unexpected similarity between NDM-1 and b-lactamase II from Erythrobacter litoralis, a marine microbial isolate, and a phylogenetic analysis of the groS and groL genes implied that plant pathogens were the potential source of the bla NDM-1 gene. 41 Therefore, to reveal the origin of the bla NDM-1 gene, further research could be concentrated on NDM-1-producing bacteria isolated from different environments.
In summary, we investigated the prevalence of bla NDM-1 in non-baumannii Acinetobacter spp. and concluded that the NDM-1-producing isolates are not yet a serious problem in China. However, attention should be given to detecting, monitoring and controlling their dissemination because this resistance gene resides in an ISAba125-associated transposon with potential transferability.
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